Elite Pharmaceuticals Inc (ELTP) financial statements (2021 and earlier)

Company profile

Business Address 165 LUDLOW AVENUE
NORTHVALE, NJ 07647
State of Incorp. NV
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments512711127
Cash and cash equivalents512711127
Receivables3411121
Inventory, net of allowances, customer advances and progress billings5455633
Inventory5455633
Deferred costs     00
Other undisclosed current assets1111000
Total current assets:1510914181712
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment7789986
Intangible assets, net (including goodwill)7778666
Intangible assets, net (excluding goodwill)7778666
Restricted cash and investments      0
Other noncurrent assets0000011
Other undisclosed noncurrent assets      (0)
Total noncurrent assets:14151617161514
TOTAL ASSETS:29252431343226
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5653224
Accounts payable121212 
Accrued liabilities554211 
Other undisclosed accounts payable and accrued liabilities      4
Deferred revenue00
Debt2211000
Due to related parties     11
Deferred revenue and credits1110
Other undisclosed current liabilities0 1  00
Total current liabilities:7975355
Noncurrent Liabilities
Long-term debt and lease obligation3222222
Long-term debt, excluding current maturities3222222
Operating lease, liability 0
Liabilities, other than long-term debt0012241
Deferred revenue and credits1230
Deferred revenue00
Due to related parties  11   
Other liabilities0000011
Other undisclosed noncurrent liabilities243311053
Total noncurrent liabilities:566751656
Total liabilities:1214131292161
Temporary equity, carrying amount  14  44 
Stockholders' equity
Stockholders' equity attributable to parent, including:1711(3)526(33)(35)
Preferred stock 14     
Common stock1111111
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital164150149147164109161
Accumulated deficit(148)(154)(152)(143)(139)(143)(196)
Other undisclosed stockholders' equity attributable to parent      (0)
Other undisclosed stockholders' equity   14  0
Total stockholders' equity:1711(3)1826(33)(35)
TOTAL LIABILITIES AND EQUITY:29252431343226

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues33188710125
Revenue, net710125
Cost of revenue(17)(10)(5)(4)(6)(4)(3)
Gross profit:16834482
Operating expenses(8)(10)(12)(13)(11)(16)(19)
Other undisclosed operating income      0
Operating income (loss):8(2)(9)(9)(7)(8)(17)
Nonoperating income (expense)20(1)49745
Other nonoperating income (expense)20(1)49  
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:9(3)(10)(5)2(1)29
Other undisclosed income (loss) from continuing operations before income taxes(0)000000
Income (loss) from continuing operations before income taxes:9(2)(10)(5)2(1)29
Income tax benefit1 11210
Income (loss) from continuing operations:10(2)(9)(4)4(1)29
Loss from discontinued operations(1) (1)    
Income (loss) before gain (loss) on sale of properties:9(2)(10)(4)4(1)29
Other undisclosed net income (loss)1(0)     
Net income (loss):10(2)(10)(4)4(1)29
Other undisclosed net income attributable to parent  1    
Net income (loss) attributable to parent:10(2)(9)(4)4(1)29
Other undisclosed net income (loss) available to common stockholders, basic    21(9) 
Net income (loss) available to common stockholders, basic:10(2)(9)(4)25(10)29
Other undisclosed net income (loss) available to common stockholders, diluted11(0)(5)(30) (44)
Net income (loss) available to common stockholders, diluted:11(1)(9)(8)(6)(10)(15)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net income (loss):10(2)(10)(4)4(1)29
Comprehensive income (loss), net of tax, attributable to parent:10(2)(10)(4)4(1)29

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: